Evidence map›Paper›PMID 42448957›Full record

ArticleEMBO reports2026

Novel CDK-independent function of CDC25 phosphatases in mRNA translation.

Sauyeun Shin, Marie Cargnello, Lisa Pinchedé, Claire Medale Giamarchi, Cléa Villette, Alexandre Gay, Virginie Salnot, Emilie-Fleur Gautier, Erik Dassi, Stefania Millevoi and 2 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sauyeun ShinUniversity of Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Marie Cargnello *University of Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Lisa Pinchedé *University of Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Claire Medale GiamarchiUniversity of Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Cléa VilletteUniversity of Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Alexandre GayUniversity of Toulouse, INSERM, CNRS, CRCT, Toulouse, France.
Virginie SalnotProteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.ORCID 0000-0002-7530-4493
Emilie-Fleur GautierProteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.
Erik DassiLaboratory of RNA Regulatory Networks, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.ORCID 0000-0003-4487-0449
Stefania MillevoiUniversity of Toulouse, INSERM, CNRS, CRCT, Toulouse, France. stefania.millevoi@inserm.fr.ORCID 0000-0003-1659-3552
Anne Cammas *University of Toulouse, INSERM, CNRS, CRCT, Toulouse, France. anne.cammas@inserm.fr.ORCID 0000-0002-3240-9172
Stéphane Manenti *University of Toulouse, INSERM, CNRS, CRCT, Toulouse, France. stephane.manenti@inserm.fr.ORCID 0000-0002-4793-3196

Funding

Institut National Du Cancer (INCa) PL BIO 2022-101
6 · The paper itself

Abstract

Molecular and functional networks driving coordination between cell cycle and mRNA translation remain to be explored. Here, we use mass spectrometry-based proteomics to comprehensively investigate the interactome and phosphoproteome of the cell cycle regulator CDC25A. We identify actors of mRNA regulation, such as RNA-binding proteins and translation factors, as interacting partners of CDC25A. CDC25A overexpression increases global translation, whereas catalytic inactivation or pharmacological inhibition decreases protein synthesis. A Cyclin-Dependent Kinase (CDK) interaction-deficient mutant of CDC25A also enhances translation, indicating a CDK-independent role. Our results further reveal an interplay between CDC25A and CDC25B whereby downregulation of CDC25A leads to compensatory overexpression of CDC25B. The roles of CDC25A and CDC25B in mRNA translation are independent of their roles in the cell cycle, with CDC25A possibly regulating translation elongation and CDC25B rather involved in initiation. In acute myeloid leukemia cells, CDC25A depletion also inhibits translation, suggesting its potential relevance as a therapeutic target. We propose that CDC25 phosphatases might be signaling platforms coordinating cell cycle progression with protein synthesis.

Indexed as

cdc25 PhosphatasesCyclin-Dependent KinasesProtein BiosynthesisRNA, MessengerCell CycleHumansProtein BindingProteomicsRNA-Binding ProteinsCDC25A protein, humanCDC25B protein, humancdc25 PhosphatasesCyclin-Dependent KinasesRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID42448957
PMCPMC13503811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.